Nuffield Health’s latest annual report reveals a turnover of £554.6m in 2010, a small increase of 0.3 per cent on the previous year.

Its EBITDA* was up 4 per cent to £68.5m and the charity broke even at net surplus level, allowing it to reinvest £88m in acquisitions and capital investments.

These investments included the acquisition of Bladerunner Ltd and Mythbreaker Ltd, alongside efforts to improve existing infrastructure and support joint ventures.

A similar level of reinvestment is expected over this year.

 

*Earnings before interest, taxes, depreciation and amortization